Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Research governance: regulating risk and reducing harm?

    Shaw S, Barrett G.

    J R Soc Med. 2006 Jan;99(1):14-9. Review.PMID: 16388050 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Regulation and the social licence for medical research.

    Dixon-Woods M, Ashcroft RE.

    Med Health Care Philos. 2008 Dec;11(4):381-91. Epub 2008 Jul 17.PMID: 18633729 [PubMed - indexed for MEDLINE]Related articles

    4.

    The Department of Health's research governance framework remains an impediment to multi-centre studies: findings from a national descriptive study.

    Kielmann T, Tierney A, Porteous R, Huby G, Sheikh A, Pinnock H.

    J R Soc Med. 2007 May;100(5):234-8.PMID: 17470931 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Research governance: where did it come from, what does it mean?

    Shaw S, Boynton PM, Greenhalgh T.

    J R Soc Med. 2005 Nov;98(11):496-502. Review.PMID: 16260798 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Research governance delays for a multicentre non-interventional study.

    Mallick AA, O'Callaghan FJ.

    J R Soc Med. 2009 May;102(5):195-8.PMID: 19417052 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Microbicide research in developing countries: have we given the ethical concerns due consideration?

    Moodley K.

    BMC Med Ethics. 2007 Sep 19;8:10.PMID: 17877834 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Understanding institutional review boards: practical guidance to the IRB review process.

    Pech C, Cob N, Cejka JT.

    Nutr Clin Pract. 2007 Dec;22(6):618-28. Review.PMID: 18042949 [PubMed - indexed for MEDLINE]Related articles

    9.

    Engagement, reciprocity and advocacy: ethical harm reduction practice in research with injecting drug users.

    Higgs P, Moore D, Aitken C.

    Drug Alcohol Rev. 2006 Sep;25(5):419-23.PMID: 16939936 [PubMed - indexed for MEDLINE]Related articles

    10.

    Risk to researchers in qualitative research on sensitive topics: issues and strategies.

    Dickson-Swift V, James EL, Kippen S, Liamputtong P.

    Qual Health Res. 2008 Jan;18(1):133-44.PMID: 18174541 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical research: protection of the "vulnerable"?

    Park SS, Grayson MH.

    J Allergy Clin Immunol. 2008 May;121(5):1103-7. Epub 2008 Mar 4. Review.PMID: 18313131 [PubMed - indexed for MEDLINE]Related articles

    12.

    Research governance: current knowledge among clinical researchers.

    Babl FE, Sharwood LN.

    Med J Aust. 2008 Jun 2;188(11):649-52.PMID: 18513174 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Understanding population and individual risk assessment: the case of polychlorinated biphenyls.

    Shields PG.

    Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):830-9. Review. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1421. PMID: 16702358 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of administering sexually explicit questionnaires on anger, anxiety, and depression in sexually abused and nonabused females: implications for risk assessment.

    Savell JK, Kinder BN, Young MS.

    J Sex Marital Ther. 2006 Mar-Apr;32(2):161-72.PMID: 16418106 [PubMed - indexed for MEDLINE]Related articles

    15.

    Children as research subjects: moral disputes, regulatory guidance, and recent court decisions.

    Kopelman LM.

    Mt Sinai J Med. 2006 May;73(3):596-604.PMID: 16758097 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Research in children: assessing risks and benefits.

    Korenman SG.

    Pediatr Res. 2004 Aug;56(2):165-6. No abstract available. PMID: 15266046 [PubMed - indexed for MEDLINE]Related articles

    17.

    Non-interventional research and usual care: definition, regulatory aspects, difficulties and recommendations.

    Lemaire F, Ravoire S, Golinelli D; participants in Round Table No5, Giens XXIII.

    Therapie. 2008 Mar-Apr;63(2):103-6, 97-101. Epub 2008 Jun 20. English, French. PMID: 18561882 [PubMed - indexed for MEDLINE]Related articles

    18.

    A comprehensive analysis of MRI research risks: in support of full disclosure.

    Marshall J, Martin T, Downie J, Malisza K.

    Can J Neurol Sci. 2007 Feb;34(1):11-7. Review.PMID: 17352342 [PubMed - indexed for MEDLINE]Related articles

    19.

    One step forward, two steps back--requiring ministerial approval for all "non-therapeutic" health research involving minors.

    Strode AE, Slack CM, Wassenaar DR, Singh JA.

    S Afr Med J. 2007 Mar;97(3):200-2.PMID: 17440668 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Public health implications of smokeless tobacco use as a harm reduction strategy.

    Savitz DA, Meyer RE, Tanzer JM, Mirvish SS, Lewin F.

    Am J Public Health. 2006 Nov;96(11):1934-9. Epub 2006 Oct 3. Erratum in: Am J Public Health. 2007 Feb;97(2):202. PMID: 17018821 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data